| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |